共 50 条
- [41] Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral DosesClinical Drug Investigation, 2012, 32 (7) : 475 - 486Beining GuoXiaojie WuYingyuan ZhangYaoguo ShiJicheng YuGuoying CaoJing Zhang
- [42] Population Pharmacokinetic and Pharmacodynamic Analysis of Plasma Aβ40 and Aβ42 Following Single Oral Doses of the BACE1 Inhibitor AZD3839 to Healthy VolunteersCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (05): : 396 - 405Quartino, AngelicaHuledal, GunillaSparve, ErikLuttgen, MariaBueters, TjerkKarlsson, ParOlsson, TinaParaskos, JonathanMaltby, JustineClaeson-Bohnstedt, KristinaLee, Chi-MingAlexander, RobertFalting, JohannaPaulsson, Bjorn
- [43] TRAP-INDUCED PLATELET AGGREGATION FOLLOWING SINGLE AND MULTIPLE RISING ORAL DOSES OF SCH 530348, A NOVEL THROMBIN RECEPTOR ANTAGONIST, IN HEALTHY VOLUNTEERSCLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S21 - S21Kosoglou, T.Reyderman, L.Tiessen, R.Fales, R. R.Cutler, D. L.Keller, R.Yang, B.Van Lier, J. J.Wadham, A.Van Vliet, A. A.
- [44] SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTSJOURNAL OF HEPATOLOGY, 2009, 50 : S229 - S229Ke, J.Lawitz, E.Rozier, R.Marbury, T.Nguyen, N.Serra, D.Dole, K.Praestgaard, J.Huang, M.Evans, T.
- [45] Results of a safety, tolerability and pharmacokinetic phase I study of VCH-916, a novel polymerase inhibitor for HCV, following single ascending doses in healthy volunteersJOURNAL OF HEPATOLOGY, 2008, 48 : S320 - S321Proulx, L.Bourgault, B.Chauret, N.Larouche, R.Tanguay, M.Thibert, R.
- [46] In pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses in healthy volunteers (vol 40, pg 410, 2000)JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (06): : 664 - 664Viegas, TXOmura, GAStoltz, RRKisicki, JT
- [47] DOSE-DEPENDENT SUPPRESSION OF T CELL-DEPENDENT ANTIBODY RESPONSE IN HEALTHY VOLUNTEERS BY KPL-404, AN ANTI-CD40 MONOCLONAL ANTIBODY, SUPPORTS CHRONIC DOSING STUDY IN PATIENTS WITH RHEUMATOID ARTHRITISANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1316 - 1317Papandrikopoulou, A.Burmester, G. R.Fang, F.Kivitz, A.Njenga, M.Pano, A.Pitzalis, C.Samant, M.Schmitz, S.Spiers, M.Tessari, E.Ziemniak, J.Paolini, J. F.
- [48] Dose-dependent Suppression of T Cell-Dependent Antibody Response in Healthy Volunteers by KPL-404, an Anti-CD40 Monoclonal Antibody, Supports Phase 2 Study in Patients with Rheumatoid ArthritisARTHRITIS & RHEUMATOLOGY, 2022, 74 : 609 - 610Pupim, LaraBurmester, GerdFang, FangKivitz, AlanNjenga, MosesPitzalis, CostantinoChatfield, JayPapandrikopoulou, AnastassiaSamant, ManojSchmitz, SteveSpiers, MadelineTessari, EbenZiemniak, JohnPaolini, John F.
- [49] Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral dosesJOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (03) : 706 - 714Baldoni, DanielaGutierrez, MarceloTimmer, WolfgangDingemanse, Jasper
- [50] ANTIVIRAL ACTIVITY, PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF PSI-7851, A NOVEL NUCLEOTIDE POLYMERASE INHIBITOR FOR HCV, FOLLOWING SINGLE AND 3 DAY MULTIPLE ASCENDING ORAL DOSES IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC HCV INFECTIONHEPATOLOGY, 2009, 50 (06) : 11A - 11ARodriguez-Torres, MaribelLawitz, EricFlach, StephenDenning, Jill M.Albanis, EfseviaSymonds, WilliamBerrey, M. M.